KSC 2021 | 65th Annual Scientific Meeting of The Korean Society of Cardiology

Program at a Glance

Symposium
Scientific Session [Bayer]
Patient Protection in Focus: Role of Rivaroxaban in High Risk Vascular Disease Patients
Oct. 18 (Mon.) 11:50-12:30, Channel 1

11:50 - 12:10

Clinical Benefits of Rivaroxaban in Patients with AF and Vascular Disease

[Speaker] Yong Soo Baek/Inha Univ.,Korea

12:10 - 12:30

What Is Optimal Anti-thrombotic Treatment Strategy in Poly-vascular Patients?

[Speaker] Min-Ku, Chon/Pusan National Univ.,Korea